The civic record
Read. Follow. Verify.Massachusetts bill allows businesses to stock epinephrine auto-injectors and provides liability protections
Last action · February 26, 2026: Accompanied a study order, see S2972Sponsors: Will Brownsberger and 1 other
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
The Massachusetts Department of Public Health is directed to establish regulations allowing businesses and other entities to acquire and store s for emergency use on individuals experiencing . The bill authorizes trained employees to administer the devices and provides civil liability protection for participating businesses, healthcare professionals, and trainers against claims. Additionally, the department must adopt implementing rules within 180 days, establish training program standards, and compile annual incident reports.
Changes emergency preparedness requirements for participating Massachusetts businesses by permitting them to maintain epinephrine supplies and establishing clear liability standards for staff who administer them during severe allergic reactions.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
businesses and other entities
Permitted to acquire and store epinephrine auto-injectors, subject to training, reporting, and secure storage regulations while receiving liability protections.
employees, designated individuals, and agents
Authorized to administer epinephrine auto-injectors after completing required training, with immunity from ordinary negligence liability.
Department of Public Health
Required to promulgate regulations, establish training standards, compile annual incident reports, and optionally run a certification program.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Can any business employee administer an epinephrine auto-injector under this bill?
Are businesses liable if something goes wrong during the administration of an auto-injector?
What reporting requirements are placed on businesses that stock epinephrine auto-injectors?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently in committee. The next step in the legislative lifecycle is Floor Vote.
Procedural history
5 actions- Feb 26, 2026SenateAccompanied a study order, see S2972
- Jan 7, 2026SenateCommitteeBill reported favorably by committee and referred to the committee on Health Care Financing
- Jun 6, 2025JointHearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- Feb 27, 2025HouseHouse concurred
- Feb 27, 2025SenateCommitteeReferred to the committee on Public Health
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
malegislature.gov
Analysis Score
0–100- Significance60How much this matters to a regular citizen
- Controversy15Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz25Current news / social attention level
Publisher tools